Ujjivan Financial Services looks attractive: Deepak Shenoy

Deepak Shenoy of Capitalmind.in told CNBC-TV18, "Ujjivan Financial Services is definitely attractive, at this price it is not a huge listing pop. I believe that as a price to book, we are getting a reasonable valuation for a small bank that is coming up.""I believe Thyrocare Technologies is probably at this point out of my value range. So, I don’t think there is a huge upside from here other than momentum which may propel the stock. I would actually prefer a Dr Lal PathLabs at this price compared to a Thyrocare. Just my personal view on this topic, nothing wrong with Thyrocare but it is just that valuations are too high," he added.At 12:45 hrs Ujjivan Financial Services was quoting at Rs 240.30, up Rs 30.30, or 14.43 percent.